| 8001 | SUSD1 levels | GCST90470786 | 0.10 |
| 8002 | Prostate cancer | GCST90428117 | 0.10 |
| 8003 | Brugada syndrome | GCST90295916 | 0.10 |
| 8004 | Cholecystectomy | FING00000273 | 0.10 |
| 8005 | PLA2G4A levels | GCST90470248 | 0.10 |
| 8006 | LRP1 levels | GCST90469797 | 0.10 |
| 8007 | TFPI levels | GCST90470839 | 0.10 |
| 8008 | CRADD/EDAR ratio | GCST90314235 | 0.10 |
| 8009 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T450 | ECGU000450 | 0.10 |
| 8010 | Phospholipids in very large VLDL | GCST90500644 | 0.10 |
| 8011 | Neutrophil count | GCST004629 | 0.10 |
| 8012 | ACVRL1/SCARB2 ratio | GCST90313157 | 0.10 |
| 8013 | FOLR2 levels | GCST90469260 | 0.10 |
| 8014 | Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers) | FING00000768 | 0.10 |
| 8015 | Granulocyte count | GCST004614 | 0.09 |
| 8016 | CDK8_CCNC levels | GCST90240825 | 0.09 |
| 8017 | Free cholesterol to total lipids in large HDL percentage (UKB data field 23637) | GCST90269734 | 0.09 |
| 8018 | PAM levels | GCST90470156 | 0.09 |
| 8019 | EIF4G1/PLA2G4A ratio | GCST90314638 | 0.09 |
| 8020 | SLURP1 levels | GCST90470674 | 0.09 |
| 8021 | LMNB1 levels | GCST90469781 | 0.09 |
| 8022 | DUT levels | GCST90469054 | 0.09 |
| 8023 | IDP dMRI ProbtrackX L1 cgc l | GCST90004250 | 0.09 |
| 8024 | Tyrosine levels (UKB data field 23469) | GCST90269566 | 0.09 |
| 8025 | Total cholines levels | GCST90497183 | 0.09 |
| 8026 | SNAP29 levels | GCST90470692 | 0.09 |
| 8027 | BA-exvivo rh volume MT | GCST90002860 | 0.09 |
| 8028 | F2R/SNX9 ratio | GCST90314736 | 0.09 |
| 8029 | CD83/LAMP3 ratio | GCST90313906 | 0.09 |
| 8030 | GKN1 levels | GCST90469353 | 0.09 |
| 8031 | LGALS7_LGALS7B/WFDC12 ratio | GCST90315317 | 0.09 |
| 8032 | SIT1 levels | GCST90470644 | 0.09 |
| 8033 | C8B levels | GCST90468503 | 0.09 |
| 8034 | Free cholesterol levels in medium HDL | GCST90092896 | 0.09 |
| 8035 | 1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels | GCST90200685 | 0.09 |
| 8036 | Beetroot liking | GCST90094702 | 0.09 |
| 8037 | Sum basophil neutrophil counts | GCST004620 | 0.09 |
| 8038 | Ever sought or received professional help for mental distress | Mental distress | UKBB00000222 | 0.09 |
| 8039 | IL6ST/MARCO ratio | GCST90315167 | 0.09 |
| 8040 | Chronic bronchitis | GCST90018604 | 0.09 |
| 8041 | Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI) | GCST003658 | 0.09 |
| 8042 | GTPBP2 levels | GCST90469417 | 0.09 |
| 8043 | AKT1S1/TDRKH ratio | GCST90313233 | 0.09 |
| 8044 | FSTL3 levels | GCST90425765 | 0.09 |
| 8045 | PRG2 levels | GCST90470322 | 0.09 |
| 8046 | SLITRK2 levels | GCST90470670 | 0.09 |
| 8047 | OMG levels | GCST90470124 | 0.09 |
| 8048 | Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions) | FING00000694 | 0.09 |
| 8049 | GP6/HPCAL1 ratio | GCST90314963 | 0.09 |
| 8050 | EFEMP1/IL18BP ratio | GCST90314596 | 0.09 |
| 8051 | Facial ageing | Sun exposure | UKBB00000233 | 0.09 |
| 8052 | Spread type: Flora Pro-Active/Benecol (UKB data field 1428_2) | GCST90132957 | 0.09 |
| 8053 | CD99/RELT ratio | GCST90313930 | 0.09 |
| 8054 | MERTK levels | GCST90469890 | 0.09 |
| 8055 | Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581) | GCST90269678 | 0.09 |
| 8056 | Pregnancy hypertension | FING00001204 | 0.09 |
| 8057 | FADD/PLIN3 ratio | GCST90314772 | 0.09 |
| 8058 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 0.09 |
| 8059 | Frequency of walking for pleasure in last 4 weeks | Physical activity | UKBB00000271 | 0.09 |
| 8060 | MGLL levels | GCST90469901 | 0.09 |
| 8061 | monocyte (absolute count, mean, inv-norm transformed) | GCST90475502 | 0.09 |
| 8062 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499800 | 0.09 |
| 8063 | NCAM2 levels | GCST90470004 | 0.09 |
| 8064 | DKK1 levels | GCST90468997 | 0.09 |
| 8065 | TGFA levels | GCST90470842 | 0.09 |
| 8066 | SUMF1 levels | GCST90470783 | 0.09 |
| 8067 | EGF levels | GCST90469086 | 0.09 |
| 8068 | ITGA6 levels | GCST90469636 | 0.09 |
| 8069 | RP2 levels | GCST90470493 | 0.09 |
| 8070 | IDP dMRI TBSS OD Fornix | GCST90004407 | 0.09 |
| 8071 | DTI TBSS L3 Superior cerebellar peduncle R | GCST90384536 | 0.09 |
| 8072 | Benign leiomyoma with endometriosis (controls excluding all cancers) | FING00000145 | 0.09 |
| 8073 | AHSP levels | GCST90468264 | 0.09 |
| 8074 | NUDT5 levels | GCST90470107 | 0.09 |
| 8075 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 0.09 |
| 8076 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 0.09 |
| 8077 | TDRKH/TST ratio | GCST90315913 | 0.09 |
| 8078 | ThalamNuclei lh volume PuA | GCST90002720 | 0.09 |
| 8079 | Principal component-derived dietary pattern 23 | GCST90133028 | 0.09 |
| 8080 | IDP T2 FLAIR BIANCA WMH volume | GCST90003862 | 0.09 |
| 8081 | Lupus erythematosus | FING00000739 | 0.09 |
| 8082 | Anti-human herpes virus 6 IE1A IgG seropositivity | GCST90006903 | 0.09 |
| 8083 | CALCOCO1/IRAG2 ratio | GCST90313604 | 0.09 |
| 8084 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T499 | ECGU000499 | 0.09 |
| 8085 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476343 | 0.09 |
| 8086 | TSHB levels | GCST90470974 | 0.09 |
| 8087 | SMPDL3A levels | GCST90470686 | 0.09 |
| 8088 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396 | ECGU000396 | 0.09 |
| 8089 | Other ulcerative colitis | FING00001117 | 0.09 |
| 8090 | Oral glucose tolerance test-0h | GCST90566421 | 0.09 |
| 8091 | Total fatty acid levels | GCST90500061 | 0.09 |
| 8092 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 0.09 |
| 8093 | ERP29 levels | GCST90469149 | 0.09 |
| 8094 | IL16/NADK ratio | GCST90315152 | 0.09 |
| 8095 | ICAM3/NOTCH1 ratio | GCST90315122 | 0.09 |
| 8096 | TNFAIP8L2 levels | GCST90470897 | 0.09 |
| 8097 | CD27/CD79B ratio | GCST90313770 | 0.09 |
| 8098 | ACOT13 levels | GCST90468200 | 0.09 |
| 8099 | TAX1BP3 levels | GCST90242976 | 0.09 |
| 8100 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 0.09 |
| 8101 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 0.09 |
| 8102 | Uterine fibroids | GCST90468154 | 0.08 |
| 8103 | Coffee difference liking | GCST90094738 | 0.08 |
| 8104 | Phospholipids in very large HDL | GCST90500458 | 0.08 |
| 8105 | Pre-eclampsia or poor fetal growth | FING00001202 | 0.08 |
| 8106 | LATS1 levels | GCST90469740 | 0.08 |
| 8107 | Total lipid levels in HDL | GCST90092825 | 0.08 |
| 8108 | Drusen (degenerative) of retina (PheCode 362.27) | GCST90475855 | 0.08 |
| 8109 | Olsenella C abundance in stool | GCST90032493 | 0.08 |
| 8110 | Urate | Blood biochemistry | UKBB00000884 | 0.08 |
| 8111 | aseg rh volume Putamen | GCST90002639 | 0.08 |
| 8112 | ERBB4/F3 ratio | GCST90314690 | 0.08 |
| 8113 | N-acetylphenylalanine levels in chronic kidney disease | GCST90257537 | 0.08 |
| 8114 | Allergic contact dermatitis | FING00000068 | 0.08 |
| 8115 | F11R levels | GCST90469164 | 0.08 |
| 8116 | YAP1 levels | GCST90471086 | 0.08 |
| 8117 | Height decline (difference score) | GCST90565863 | 0.08 |
| 8118 | Oral glucose tolerance test-1h | GCST90297789 | 0.08 |
| 8119 | Liver enzyme levels (alanine transaminase) | GCST90013405 | 0.08 |
| 8120 | Creatinine levels (UKB data field 30700) | GCST90468067 | 0.08 |
| 8121 | BCL2L11 levels | GCST90468430 | 0.08 |
| 8122 | IL2RB levels | GCST90469586 | 0.08 |
| 8123 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | GCST90269681 | 0.08 |
| 8124 | Cholesteryl ester levels in very large HDL | GCST90093006 | 0.08 |
| 8125 | Behenoyl dihydrosphingomyelin (d18:0/22:0) levels | GCST90200059 | 0.08 |
| 8126 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000388 | 0.08 |
| 8127 | GRAP2 levels | GCST90469399 | 0.08 |
| 8128 | APOL1 levels | GCST90468341 | 0.08 |
| 8129 | CPM levels | GCST90468843 | 0.08 |
| 8130 | Gout (PheCode 274.1) | GCST90475735 | 0.08 |
| 8131 | ALCAM/ICAM3 ratio | GCST90313237 | 0.08 |
| 8132 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T386 | ECGU000386 | 0.08 |
| 8133 | F-fish liking (derived food-liking factor) | GCST90094762 | 0.08 |
| 8134 | TFRC levels | GCST90451684 | 0.08 |
| 8135 | Smoking status (standard GWA) | GCST90267302 | 0.08 |
| 8136 | REST UKBBICA NET100 1287 | GCST90387141 | 0.08 |
| 8137 | ABL1 levels | GCST90468190 | 0.08 |
| 8138 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 0.08 |
| 8139 | Reticulocyte count (UKB data field 30250) | GCST90468100 | 0.08 |
| 8140 | MYDGF levels | GCST90469972 | 0.08 |
| 8141 | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels | GCST90200067 | 0.08 |
| 8142 | Microscopic polyangiitis | FING00000817 | 0.08 |
| 8143 | Acute peritonitis | FING00000028 | 0.08 |
| 8144 | Guanidinoacetate levels | GCST90200384 | 0.08 |
| 8145 | NPPB levels | GCST90470074 | 0.08 |
| 8146 | CTSD/PRCP ratio | GCST90314312 | 0.08 |
| 8147 | CCL27 levels | GCST90468579 | 0.08 |
| 8148 | Non-cancer illness year/age first occurred | Medical conditions | UKBB00000523 | 0.08 |
| 8149 | LCP1 levels | GCST90469748 | 0.08 |
| 8150 | aseg global volume BrainSegNotVent | GCST90002591 | 0.08 |
| 8151 | Palmar fascial fibromatosis [Dupuytren] | FING00001141 | 0.08 |
| 8152 | Benign neoplasm of skin (PheCode 216) | GCST90475620 | 0.08 |
| 8153 | Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney disease | GCST90264508 | 0.08 |
| 8154 | wg rh intensity-contrast lateralorbitofrontal | GCST90003838 | 0.08 |
| 8155 | LDL direct, adjusted by medication | Lipid or lipoprotein measurement | UKBB00000387 | 0.08 |
| 8156 | Lifespan | GCST90551886 | 0.08 |
| 8157 | Principal component-derived dietary pattern 35 | GCST90133040 | 0.08 |
| 8158 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 0.08 |
| 8159 | LDLR levels | GCST90469750 | 0.08 |
| 8160 | SF3B4 levels | GCST90470609 | 0.08 |
| 8161 | FKBP14 levels | GCST90469241 | 0.08 |
| 8162 | Cholesterol to Total Lipids in Small VLDL percentage | GCST90499764 | 0.08 |
| 8163 | 1-arachidonoylglycerophosphoethanolamine levels | GCST90243808 | 0.08 |
| 8164 | CXCL12/TIMP3 ratio | GCST90314338 | 0.08 |
| 8165 | Chronic pain (confirmatory factor analysis Factor 18) | GCST90309352 | 0.08 |
| 8166 | Phospholipids in large VLDL | GCST90498243 | 0.08 |
| 8167 | Aspartate aminotransferase levels (UKB data field 30650) | GCST90468063 | 0.08 |
| 8168 | CD74/TNFRSF21 ratio | GCST90313897 | 0.08 |
| 8169 | aparc-DKTatlas rh volume precuneus | GCST90002916 | 0.08 |
| 8170 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 0.08 |
| 8171 | Estimated glomerular filtration rate (creatinine) | GCST90428447 | 0.08 |
| 8172 | RWDD1/SUMF2 ratio | GCST90315795 | 0.08 |
| 8173 | CHAD levels | GCST90468737 | 0.08 |
| 8174 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475450 | 0.08 |
| 8175 | GRPEL1 levels | GCST90469405 | 0.08 |
| 8176 | Percent liver fat | GCST90016673 | 0.08 |
| 8177 | AGT levels | GCST90468257 | 0.08 |
| 8178 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 0.08 |
| 8179 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12) | GCST90320831 | 0.08 |
| 8180 | BCL2L1 levels | GCST90468432 | 0.08 |
| 8181 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453 | ECGU000453 | 0.08 |
| 8182 | HSPA1A levels | GCST90469487 | 0.08 |
| 8183 | aparc-a2009s lh volume G-front-inf-Triangul | GCST90002938 | 0.08 |
| 8184 | Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletal | UKBB00000758 | 0.08 |
| 8185 | KLK8 levels | GCST90422316 | 0.07 |
| 8186 | TEX101 levels | GCST90470832 | 0.07 |
| 8187 | CLPS/CTRB1 ratio | GCST90314139 | 0.07 |
| 8188 | Treatment/medication code - ibuprofen | Medications | UKBB00000847 | 0.07 |
| 8189 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668505 | 0.07 |
| 8190 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 0.07 |
| 8191 | SIGLEC9 levels | GCST90470637 | 0.07 |
| 8192 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395 | ECGU000395 | 0.07 |
| 8193 | White bread liking | GCST90094865 | 0.07 |
| 8194 | White blood cell count (basophil) | GCST004618 | 0.07 |
| 8195 | IRF3 levels | GCST90618743 | 0.07 |
| 8196 | F-bitter food liking (derived food-liking factor) | GCST90094706 | 0.07 |
| 8197 | DEFB4A or DEFB4B levels | GCST90468984 | 0.07 |
| 8198 | APBB1IP/POLR2F ratio | GCST90313300 | 0.07 |
| 8199 | CFHR1 levels | GCST90618503 | 0.07 |
| 8200 | UXS1 levels | GCST90471023 | 0.07 |
| 8201 | PSRC1/SMAD1 ratio | GCST90315741 | 0.07 |
| 8202 | N-acetyl-2-aminoadipate levels | GCST90200268 | 0.07 |
| 8203 | FOXO3 levels | GCST90469266 | 0.07 |
| 8204 | Percentage of M9 (GP18) | GCST90668696 | 0.07 |
| 8205 | PLXDC2 levels | GCST90470264 | 0.07 |
| 8206 | CXCL5 levels | GCST90000461 | 0.07 |
| 8207 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 0.07 |
| 8208 | LGMN/SPINT2 ratio | GCST90315324 | 0.07 |
| 8209 | Hydrocele (PheCode 603.1) | GCST90476157 | 0.07 |
| 8210 | Idiopathic gout | FING00000658 | 0.07 |
| 8211 | Cholesteryl Esters in Large HDL | GCST90497753 | 0.07 |
| 8212 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 0.07 |
| 8213 | KLK14 levels | GCST90427428 | 0.07 |
| 8214 | Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302677 | 0.07 |
| 8215 | PARK7/TNFRSF9 ratio | GCST90315599 | 0.07 |
| 8216 | NQO2 levels | GCST90242679 | 0.07 |
| 8217 | BTN2A1/IL18BP ratio | GCST90313545 | 0.07 |
| 8218 | Phospholipids to total lipids ratio in very large VLDL | GCST90093025 | 0.07 |
| 8219 | DKK3/LTBP2 ratio | GCST90314487 | 0.07 |
| 8220 | GRAP2/SRC ratio | GCST90314989 | 0.07 |
| 8221 | Type 1 diabetes | GCST90432066 | 0.07 |
| 8222 | Medication use (drugs affecting bone structure and mineralization) | GCST90018773 | 0.07 |
| 8223 | T1 FreeSurfer BA lh BA3a exvivo thickness | GCST90385521 | 0.07 |
| 8224 | MCTS1 levels | GCST90469874 | 0.07 |
| 8225 | CD74/DLL1 ratio | GCST90313891 | 0.07 |
| 8226 | FCN1 levels | GCST90469203 | 0.07 |
| 8227 | PRAP1 levels | GCST90470312 | 0.07 |
| 8228 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 0.07 |
| 8229 | TMSB10 levels | GCST90470894 | 0.07 |
| 8230 | Other disorders of testis (PheCode 603) | GCST90476156 | 0.07 |
| 8231 | Phospholipid levels in HDL | GCST90092827 | 0.07 |
| 8232 | Mean corpuscular haemoglobin (UKB data field 30050) | GCST90468084 | 0.07 |
| 8233 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T387 | ECGU000387 | 0.07 |
| 8234 | Mean corpuscular volume | GCST004602 | 0.07 |
| 8235 | HSPG2 levels | GCST90179392 | 0.07 |
| 8236 | CSNK2A1 levels | GCST90468889 | 0.07 |
| 8237 | CCL25 levels | GCST90468577 | 0.07 |
| 8238 | Other neurological diseases | FING00001074 | 0.07 |
| 8239 | HMCN2 levels | GCST90469461 | 0.07 |
| 8240 | RARRES2 levels | GCST90470428 | 0.07 |
| 8241 | OMD levels | GCST90470123 | 0.07 |
| 8242 | PTPRS levels | GCST90470387 | 0.07 |
| 8243 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90025432 | 0.07 |
| 8244 | IDP dMRI TBSS ICVF Cerebral peduncle L | GCST90004342 | 0.07 |
| 8245 | Triglycerides to total lipids ratio in large VLDL | GCST90092879 | 0.07 |
| 8246 | SIRT2/STAT5B ratio | GCST90315846 | 0.07 |
| 8247 | RGS18 levels | GCST90242617 | 0.07 |
| 8248 | NCK2 levels | GCST90470007 | 0.07 |
| 8249 | LPCAT2 levels | GCST90241841 | 0.07 |
| 8250 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 0.07 |
| 8251 | CRADD/MAP4K5 ratio | GCST90314240 | 0.07 |
| 8252 | Ceramide (d18:2/22:0) levels | GCST90024054 | 0.07 |
| 8253 | C4 levels | GCST90281042 | 0.07 |
| 8254 | ITGA5/LILRA2 ratio | GCST90315204 | 0.07 |
| 8255 | IDP dMRI TBSS MD Fornix | GCST90004032 | 0.07 |
| 8256 | IDP dMRI ProbtrackX ISOVF cgc r | GCST90004530 | 0.07 |
| 8257 | Visceral adipose tissue volume | GCST90016671 | 0.07 |
| 8258 | Squamous cell carcinoma (MTAG) | GCST90137412 | 0.07 |
| 8259 | CD93/TNFRSF4 ratio | GCST90313922 | 0.07 |
| 8260 | ICAM2 levels | GCST90469499 | 0.07 |
| 8261 | Epstein-Barr virus ZEBRA antibody levels | GCST90006901 | 0.07 |
| 8262 | ACAA1 levels | GCST90468193 | 0.07 |
| 8263 | Octadecenedioate (C18:1-DC) levels | GCST90200165 | 0.07 |
| 8264 | aparc-a2009s lh area G-precentral | GCST90003325 | 0.07 |
| 8265 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385 | ECGU000385 | 0.06 |
| 8266 | APOB/APOA1 ratio | GCST90269538 | 0.06 |
| 8267 | Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302820 | 0.06 |
| 8268 | Lysophosphatidylcholine (26:0) [sn2] levels | GCST90024189 | 0.06 |
| 8269 | APOB/APOA1 ratio | GCST90497156 | 0.06 |
| 8270 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 0.06 |
| 8271 | Ximenoylcarnitine (C26:1) levels | GCST90200149 | 0.06 |
| 8272 | SEZ6L2 levels | GCST90470606 | 0.06 |
| 8273 | ADAMTS13 levels | GCST90468222 | 0.06 |
| 8274 | Sensitivity / hurt feelings | Mental health | UKBB00000766 | 0.06 |
| 8275 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 7.99_210.09) | GCST90291312 | 0.06 |
| 8276 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497868 | 0.06 |
| 8277 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 0.06 |
| 8278 | MTDH levels | GCST90469954 | 0.06 |
| 8279 | IDP T1 FAST ROIs V cerebellum X | GCST90002588 | 0.06 |
| 8280 | Arthropathies | FING00000107 | 0.06 |
| 8281 | CD69/SCARF1 ratio | GCST90313885 | 0.06 |
| 8282 | Angina pectoris | circulatory system | UKBB00000030 | 0.06 |
| 8283 | Varicose veins of lower extremity, symptomtic (PheCode 454.11) | GCST90476014 | 0.06 |
| 8284 | Left ventricle sphericity index | GCST90268402 | 0.06 |
| 8285 | KIAA0319 levels | GCST90469676 | 0.06 |
| 8286 | DTI TBSS MD Tapetum L | GCST90384619 | 0.06 |
| 8287 | Pre-eclampsia or eclampsia | FING00001201 | 0.06 |
| 8288 | BLVRB/HBQ1 ratio | GCST90313525 | 0.06 |
| 8289 | CXCL12 levels | GCST90468925 | 0.06 |
| 8290 | ERBB4/UMOD ratio | GCST90314692 | 0.06 |
| 8291 | CPB1/PRSS2 ratio | GCST90314211 | 0.06 |
| 8292 | Cholesterol levels in very large HDL | GCST90500310 | 0.06 |
| 8293 | Hereditary deficiency of other clotting factors | FING00000612 | 0.06 |
| 8294 | Triglycerides in medium HDL | GCST90498672 | 0.06 |
| 8295 | IDP dMRI TBSS MD Middle cerebellar peduncle | GCST90004027 | 0.06 |
| 8296 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae) | GCST90027668 | 0.06 |
| 8297 | CRTAM/KLRD1 ratio | GCST90314277 | 0.06 |
| 8298 | GM1 ganglioside (d18:1/16:0) levels | GCST90024724 | 0.06 |
| 8299 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 0.06 |
| 8300 | METAP1D levels | GCST90469892 | 0.06 |
| 8301 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 0.06 |
| 8302 | Retinal breaks without detachment | FING00001258 | 0.06 |
| 8303 | HNMT/SETMAR ratio | GCST90315069 | 0.06 |
| 8304 | Seborrhoeic keratosis | FING00001283 | 0.06 |
| 8305 | XXYLT1 levels | GCST90243370 | 0.06 |
| 8306 | TREH levels | GCST90470959 | 0.06 |
| 8307 | F-cake/biscuits liking (derived food-liking factor) | GCST90094722 | 0.06 |
| 8308 | Cholesteryl Esters in Medium HDL | GCST90498538 | 0.06 |
| 8309 | ALB levels | GCST90018725 | 0.06 |
| 8310 | Diacylglycerol_34:3_[M+H-H2O]1+ levels | GCST90060177 | 0.06 |
| 8311 | RASSF2 levels | GCST90470431 | 0.06 |
| 8312 | AmygNuclei lh volume Whole-amygdala | GCST90002657 | 0.06 |
| 8313 | ESAM/PDGFB ratio | GCST90314714 | 0.06 |
| 8314 | SIGLEC1/SSC5D ratio | GCST90315844 | 0.06 |
| 8315 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 0.06 |
| 8316 | Breast cancer | GCST90468117 | 0.06 |
| 8317 | Blood cell traits latent factor 6 (red cell (and basophil)) | GCST90559248 | 0.06 |
| 8318 | Sardines liking | GCST90094830 | 0.06 |
| 8319 | APOA levels | GCST90468061 | 0.06 |
| 8320 | IL6ST/LEPR ratio | GCST90315165 | 0.06 |
| 8321 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T452 | ECGU000452 | 0.06 |
| 8322 | Pain medicine use during menstruation | GCST006637 | 0.06 |
| 8323 | Height decline (log-difference score) | GCST90565853 | 0.06 |
| 8324 | NCAN levels | GCST90470005 | 0.06 |
| 8325 | Creatinine levels | GCST90497237 | 0.06 |
| 8326 | Mean platelet volume during second trimester of pregnancy | GCST90302230 | 0.06 |
| 8327 | Lager liking | GCST90094789 | 0.06 |
| 8328 | Cholesterol in Large HDL | GCST90497709 | 0.06 |
| 8329 | Leucine levels (UKB data field 23466) | GCST90269563 | 0.06 |
| 8330 | THBD levels | GCST90012048 | 0.06 |
| 8331 | Principal component-derived dietary pattern 36 | GCST90133041 | 0.06 |
| 8332 | ADAMTS4 levels | GCST90468226 | 0.06 |
| 8333 | X-12749 levels | GCST90243770 | 0.06 |
| 8334 | AGRP levels | GCST90240217 | 0.06 |
| 8335 | CEACAM21 levels | GCST90468694 | 0.06 |
| 8336 | Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)? | GCST90475210 | 0.06 |
| 8337 | Levulinate 4-oxovalerate levels | GCST90243545 | 0.06 |
| 8338 | Pulse wave reflection index | Arterial stiffness | UKBB00000726 | 0.06 |
| 8339 | Cholesteryl Esters in Medium HDL | GCST90498532 | 0.06 |
| 8340 | wg rh intensity-contrast isthmuscingulate | GCST90003836 | 0.06 |
| 8341 | Cholesteryl esters in IDL (UKB data field 23527) | GCST90269624 | 0.06 |
| 8342 | F-cooking vegetables liking (derived food-liking factor) | GCST90094743 | 0.06 |
| 8343 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 0.06 |
| 8344 | Pulmonary fibrosis | GCST90018688 | 0.06 |
| 8345 | Triglycerides in large VLDL | GCST90498267 | 0.06 |
| 8346 | T1 FreeSurfer a2009s rh S collat transv ant area | GCST90384939 | 0.06 |
| 8347 | SUSD5 levels | GCST90470789 | 0.06 |
| 8348 | CLSTN2/MATN2 ratio | GCST90314143 | 0.06 |
| 8349 | IDP T1 FAST ROIs V cerebellum VIIIb | GCST90002582 | 0.06 |
| 8350 | Angina pectoris | GCST90018573 | 0.06 |
| 8351 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 0.06 |
| 8352 | Free Cholesterol to Total Lipids in Large HDL percentage | GCST90497790 | 0.06 |
| 8353 | TRIM58 levels | GCST90470969 | 0.06 |
| 8354 | Cholesterol in IDL (UKB data field 23526) | GCST90269623 | 0.06 |
| 8355 | Kidney transplant status | FING00000710 | 0.06 |
| 8356 | CR1 levels | GCST90468851 | 0.06 |
| 8357 | LEP levels | GCST90012076 | 0.06 |
| 8358 | EFNA4/TNFRSF9 ratio | GCST90314606 | 0.06 |
| 8359 | Reticulocyte count | GCST90025972 | 0.06 |
| 8360 | BMPER levels | GCST90468455 | 0.06 |
| 8361 | Gamma glutamyl transferase levels | GCST90278630 | 0.06 |
| 8362 | KLK8/LY6D ratio | GCST90315257 | 0.06 |
| 8363 | LMNB2 levels | GCST90469782 | 0.06 |
| 8364 | Mean platelet volume during the postpartum period | GCST90302233 | 0.05 |
| 8365 | FNDC1 levels | GCST90469256 | 0.05 |
| 8366 | Transient ischemic attack | FING00001375 | 0.05 |
| 8367 | IDP SWI T2star right caudate | GCST90003866 | 0.05 |
| 8368 | B4GALT1 levels | GCST90468412 | 0.05 |
| 8369 | Polyglandular dysfunction | FING00001186 | 0.05 |
| 8370 | RNASEH2A levels | GCST90470480 | 0.05 |
| 8371 | ALCAM/CDH5 ratio | GCST90313234 | 0.05 |
| 8372 | IL1RN levels | GCST90469576 | 0.05 |
| 8373 | Melanoma | GCST90011809 | 0.05 |
| 8374 | CDCP1/IL18BP ratio | GCST90313937 | 0.05 |
| 8375 | FGF2/HBEGF ratio | GCST90314811 | 0.05 |
| 8376 | MESD levels | GCST90469891 | 0.05 |
| 8377 | THBS2 levels | GCST90470854 | 0.05 |
| 8378 | Abnormal results of function study of thyro (PheCode 246.7) | GCST90475654 | 0.05 |
| 8379 | IL17A levels | GCST90469558 | 0.05 |
| 8380 | Medication for pain relief, constipation, heartburn - Laxatives (e.g. Dulcolax, Senokot) | Medication | UKBB00000456 | 0.05 |
| 8381 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 0.05 |
| 8382 | CDKN2D/MANF ratio | GCST90313989 | 0.05 |
| 8383 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 0.05 |
| 8384 | SIAE/SNAP29 ratio | GCST90315843 | 0.05 |
| 8385 | triglyceride (mean, inv-norm transformed) | GCST90476433 | 0.05 |
| 8386 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 0.05 |
| 8387 | Worry too long after an embarrassing experience | GCST006946 | 0.05 |
| 8388 | wg rh intensity-contrast rostralanteriorcingulate | GCST90003852 | 0.05 |
| 8389 | ADM levels | GCST90468246 | 0.05 |
| 8390 | Bipolar disorder | GCST003724 | 0.05 |
| 8391 | IDP T1 FIRST left caudate volume | GCST90002438 | 0.05 |
| 8392 | Breast cancer (estrogen-receptor negative) | GCST005076 | 0.05 |
| 8393 | FADD levels | GCST90469180 | 0.05 |
| 8394 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 0.05 |
| 8395 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 0.05 |
| 8396 | Chronic heart failure | GCST90018586 | 0.05 |
| 8397 | HPGDS levels | GCST90469472 | 0.05 |
| 8398 | Phospholipids to Total Lipids in Small HDL percentage | GCST90499505 | 0.05 |
| 8399 | Separation of retinal layers (serosa) | FING00001292 | 0.05 |
| 8400 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 0.05 |
| 8401 | aparc-a2009s rh volume S-intrapariet+P-trans | GCST90003054 | 0.05 |
| 8402 | Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivity | GCST90302764 | 0.05 |
| 8403 | AMBP levels | GCST90468288 | 0.05 |
| 8404 | TNFRSF19 levels | GCST90088947 | 0.05 |
| 8405 | AGRN levels | GCST90468255 | 0.05 |
| 8406 | ThalamNuclei rh volume PuI | GCST90002738 | 0.05 |
| 8407 | Usual side of head for mobile phone use - Right | Electronic device use | UKBB00000890 | 0.05 |
| 8408 | Congenital malformations of the circulatory system | FING00000340 | 0.05 |
| 8409 | Erythematous conditions (PheCode 695) | GCST90476177 | 0.05 |
| 8410 | Smoking status - Never | Smoking | UKBB00000780 | 0.05 |
| 8411 | Triglycerides in medium HDL | GCST90498667 | 0.05 |
| 8412 | T1 FreeSurfer a2009s rh G&S subcentral volume | GCST90385041 | 0.05 |
| 8413 | Skin elastin (cheek, R5) | GCST90502787 | 0.05 |
| 8414 | F-salty food liking (derived food-liking factor) | GCST90094827 | 0.05 |
| 8415 | UFD1 levels | GCST90471005 | 0.05 |
| 8416 | ANXA4 levels | GCST90468319 | 0.05 |
| 8417 | chloride (maximum, inv-norm transformed) | GCST90475192 | 0.05 |
| 8418 | BCL2L11/VASH1 ratio | GCST90313485 | 0.05 |
| 8419 | AHSP/BLVRB ratio | GCST90313214 | 0.05 |
| 8420 | Processed meat consumption | GCST90132995 | 0.05 |
| 8421 | NELL2 levels | GCST90470027 | 0.05 |
| 8422 | ACAN levels | GCST90468196 | 0.05 |
| 8423 | Creatinine levels | GCST90278624 | 0.05 |
| 8424 | Job SOC coding: Heavy goods vehicle drivers (UKB data field 22617_8211) | GCST90043552 | 0.05 |
| 8425 | Omega-3 fatty acid levels | GCST90502424 | 0.05 |
| 8426 | SEMA7A levels | GCST90470575 | 0.05 |
| 8427 | MLN levels | GCST90469913 | 0.05 |
| 8428 | REG3A levels | GCST90470449 | 0.05 |
| 8429 | CD83/HAVCR2 ratio | GCST90313904 | 0.05 |
| 8430 | BMP6/SPINT2 ratio | GCST90313529 | 0.05 |
| 8431 | CLEC1A/TNFRSF1A ratio | GCST90314085 | 0.05 |
| 8432 | ADAM8 levels | GCST90468220 | 0.05 |
| 8433 | CD84/F2R ratio | GCST90313912 | 0.05 |
| 8434 | ANGPT2 levels | GCST90468301 | 0.05 |
| 8435 | Serum urea levels | GCST90025991 | 0.05 |
| 8436 | Cholesteryl ester levels in HDL | GCST90092823 | 0.05 |
| 8437 | CELA2A levels | GCST90468701 | 0.05 |
| 8438 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T28 | ECGU000028 | 0.05 |
| 8439 | Gut microbiota abundance (k_Bacteria.p_Bacteroidetes.c_Bacteroidia.o_Bacteroidales.f_Rikenellaceae.g_Alistipes) | GCST90027701 | 0.05 |
| 8440 | SUGT1 levels | GCST90470780 | 0.05 |
| 8441 | CD164/PARK7 ratio | GCST90313743 | 0.05 |
| 8442 | Gamma glutamyltransferase levels (UKB data field 30730) | GCST90468070 | 0.05 |
| 8443 | CXCL11/VTA1 ratio | GCST90314337 | 0.05 |
| 8444 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 0.05 |
| 8445 | Principal component-derived dietary pattern 9 | GCST90133014 | 0.05 |
| 8446 | ALPI levels | GCST90468285 | 0.05 |
| 8447 | Pulmonary tuberculosis | GCST90018672 | 0.05 |
| 8448 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 0.05 |
| 8449 | FABP4 levels | GCST90012075 | 0.05 |
| 8450 | HDL cholesterol levels | GCST90092822 | 0.05 |
| 8451 | ITGAM/ITGAV ratio | GCST90315209 | 0.05 |
| 8452 | Volume of right lateral nucleus | GCST90474922 | 0.05 |
| 8453 | CD163 levels | GCST90468600 | 0.05 |
| 8454 | Milk type used - Full cream | Diet | UKBB00000468 | 0.05 |
| 8455 | CD27/TGFBR2 ratio | GCST90313776 | 0.05 |
| 8456 | HSPB6 levels | GCST90469490 | 0.05 |
| 8457 | IDO1 levels | GCST90241490 | 0.05 |
| 8458 | DNA methylation PhenoAge acceleration | GCST90014292 | 0.05 |
| 8459 | VASH1 levels | GCST90471026 | 0.05 |
| 8460 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 0.05 |
| 8461 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388 | ECGU000388 | 0.05 |
| 8462 | GSTA1/SULT2A1 ratio | GCST90314996 | 0.05 |
| 8463 | LGMN/TIMP1 ratio | GCST90315325 | 0.05 |
| 8464 | white blood cell count (WBC, minimum, inv-norm transformed) | GCST90476457 | 0.05 |
| 8465 | GOLM2 levels | GCST90469376 | 0.05 |
| 8466 | Triacylglycerol_53:4_[M+NH4]1+ levels | GCST90060524 | 0.05 |
| 8467 | CCN2/HBEGF ratio | GCST90313713 | 0.05 |
| 8468 | aparc-a2009s lh area G-oc-temp-med-Lingual | GCST90003318 | 0.05 |
| 8469 | Systemic lupus erythematosus | GCST90014238 | 0.05 |
| 8470 | NSFL1C/RILP ratio | GCST90315560 | 0.05 |
| 8471 | Smoking status, ever vs never | Other measurement | UKBB00000782 | 0.05 |
| 8472 | CTSF/CTSV ratio | GCST90314313 | 0.05 |
| 8473 | Triglycerides in large HDL | GCST90497888 | 0.05 |
| 8474 | TMPRSS11D levels | GCST90470891 | 0.05 |
| 8475 | Plateletcrit | GCST004607 | 0.05 |
| 8476 | Breast cancer | GCST010098 | 0.05 |
| 8477 | IRAK1/SPRY2 ratio | GCST90315196 | 0.05 |
| 8478 | TNFAIP8 levels | GCST90470898 | 0.05 |
| 8479 | DTD1 levels | GCST90469045 | 0.05 |
| 8480 | Monocyte count | Blood count | UKBB00000479 | 0.05 |
| 8481 | PCBD1 levels | GCST90470166 | 0.05 |
| 8482 | Benign neoplasm: Parotid gland | FING00000192 | 0.05 |
| 8483 | wg rh intensity-contrast precentral | GCST90003850 | 0.05 |
| 8484 | Phospholipids to total lipids in large LDL percentage (UKB data field 23614) | GCST90269711 | 0.04 |
| 8485 | Otitis externa, unspecified | FING00001129 | 0.04 |
| 8486 | rfMRI amplitudes (ICA100 node 7) | GCST90004595 | 0.04 |
| 8487 | TSC1 levels | GCST90470972 | 0.04 |
| 8488 | F-vegetarian liking (derived food-liking factor) | GCST90094863 | 0.04 |
| 8489 | Liver enzyme levels (gamma-glutamyl transferase) | GCST90013407 | 0.04 |
| 8490 | Hypertensive heart disease (PheCode 401.21) | GCST90475925 | 0.04 |
| 8491 | Tyrosine levels | GCST90500143 | 0.04 |
| 8492 | CD69/PLXNB3 ratio | GCST90313881 | 0.04 |
| 8493 | APOB/APOA1 ratio | GCST90092810 | 0.04 |
| 8494 | Type 2 diabetes | GCST005413 | 0.04 |
| 8495 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 8.07_212.10) | GCST90291805 | 0.04 |
| 8496 | CX3CL1/RGMB ratio | GCST90314327 | 0.04 |
| 8497 | Tyrosine levels | GCST90092993 | 0.04 |
| 8498 | Spondylolisthesis/Spondylolysis | FING00001324 | 0.04 |
| 8499 | ALB levels | GCST90278616 | 0.04 |
| 8500 | Insulin pump user (PheCode 250.3) | GCST90475680 | 0.04 |
| 8501 | Serum 25-Hydroxyvitamin D level variance | GCST90000621 | 0.04 |
| 8502 | CD99/PIK3IP1 ratio | GCST90313929 | 0.04 |
| 8503 | VWA1 levels | GCST90471061 | 0.04 |
| 8504 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 0.04 |
| 8505 | Acute pancreatitis | FING00000027 | 0.04 |
| 8506 | Free cholesterol levels in HDL | GCST90092824 | 0.04 |
| 8507 | VAMP8 levels | GCST90471025 | 0.04 |
| 8508 | Phospholipids to Total Lipids in Medium HDL percentage | GCST90498651 | 0.04 |
| 8509 | AREG levels | GCST90468347 | 0.04 |
| 8510 | FKBP5/ZBTB16 ratio | GCST90314850 | 0.04 |
| 8511 | Red blood cell (erythrocyte) count | Blood count | UKBB00000747 | 0.04 |
| 8512 | LDLR/MEGF9 ratio | GCST90315310 | 0.04 |
| 8513 | MAP2K1 levels | GCST90469851 | 0.04 |
| 8514 | Current employment status - Unable to work because of sickness or disability | Employment | UKBB00000160 | 0.04 |
| 8515 | Asthma | GCST90476024 | 0.04 |
| 8516 | ELN levels | GCST90469103 | 0.04 |
| 8517 | AFP levels | GCST90468250 | 0.04 |
| 8518 | aparc-pial rh area lateralorbitofrontal | GCST90003185 | 0.04 |
| 8519 | Low back pain | FING00000730 | 0.04 |
| 8520 | Pyruvate levels | GCST90092942 | 0.04 |
| 8521 | Reticulocyte count | GCST90002405 | 0.04 |
| 8522 | T1 FreeSurfer aseg Right-Putamen | GCST90384163 | 0.04 |
| 8523 | LY96 levels | GCST90469823 | 0.04 |
| 8524 | CD40/TIMP3 ratio | GCST90313829 | 0.04 |
| 8525 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389 | ECGU000389 | 0.04 |
| 8526 | aparc-Desikan lh volume precuneus | GCST90002792 | 0.04 |
| 8527 | HYOU1/RARRES2 ratio | GCST90315103 | 0.04 |
| 8528 | Breast cancer | GCST90429846 | 0.04 |
| 8529 | AZU1/RNASE3 ratio | GCST90313428 | 0.04 |
| 8530 | X-11444 metabolite level | GCST90616545 | 0.04 |
| 8531 | CLEC4G/KDR ratio | GCST90314118 | 0.04 |
| 8532 | Gout and other crystal arthrop (PheCode 274) | GCST90475731 | 0.04 |
| 8533 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 0.04 |
| 8534 | Primary open-angle glaucoma, strict | FING00001214 | 0.04 |
| 8535 | Hemangioma of skin and subcutaneous tissue (PheCode 228.1) | GCST90475633 | 0.04 |
| 8536 | CD160 levels | GCST90468599 | 0.04 |
| 8537 | CSF2 levels | GCST90468884 | 0.04 |
| 8538 | Time spent using computer | Physical activity | UKBB00000820 | 0.04 |
| 8539 | triglyceride (minimum, inv-norm transformed) | GCST90476439 | 0.04 |
| 8540 | Esophageal adenocarcinoma | GCST003739 | 0.04 |
| 8541 | Free Cholesterol to Total Lipids in Very Large HDL percentage | GCST90500398 | 0.04 |
| 8542 | Viral hepatitis C (PheCode 70.3) | GCST90475553 | 0.04 |
| 8543 | PDGFRA levels | GCST90470191 | 0.04 |
| 8544 | CD40LG levels | GCST90468632 | 0.04 |
| 8545 | Paternal history of Alzheimer's disease | GCST005920 | 0.04 |
| 8546 | Mild obesity-related type 2 diabetes | GCST90026415 | 0.04 |
| 8547 | MGLL/PLA2G4A ratio | GCST90315439 | 0.04 |
| 8548 | AARSD1/UBAC1 ratio | GCST90313135 | 0.04 |
| 8549 | Triacylglycerol_51:2_[M+NH4]1+ levels | GCST90060497 | 0.04 |
| 8550 | CD40LG/MPIG6B ratio | GCST90313825 | 0.04 |
| 8551 | Free cholesterol in large LDL (UKB data field 23535) | GCST90269632 | 0.04 |
| 8552 | Early-onset myasthenia gravis | GCST90093465 | 0.04 |
| 8553 | GAS6/NOTCH1 ratio | GCST90314918 | 0.04 |
| 8554 | Polyunsaturated fatty acid levels | GCST90502142 | 0.04 |
| 8555 | CD69/SNAP29 ratio | GCST90313887 | 0.04 |
| 8556 | AGR3 levels | GCST90468254 | 0.04 |
| 8557 | ANXA3/HCLS1 ratio | GCST90313282 | 0.04 |
| 8558 | Restless leg syndrome | FING00001255 | 0.04 |
| 8559 | Non-oily fish intake | Diet | UKBB00000525 | 0.04 |
| 8560 | FUT3_FUT5/LILRA2 ratio | GCST90314889 | 0.04 |
| 8561 | Triacylglycerol_53:2_[M+NH4]1+ levels | GCST90060531 | 0.04 |
| 8562 | Other cataract | Disorders of lens | UKBB00000602 | 0.04 |
| 8563 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 0.04 |
| 8564 | CPB1 levels | GCST90468839 | 0.04 |
| 8565 | Myocardial fractal dimension (slice 5) | GCST90000291 | 0.04 |
| 8566 | Abdominal fat ratio | GCST90267360 | 0.04 |
| 8567 | HBEGF/YES1 ratio | GCST90315039 | 0.04 |
| 8568 | Glaucoma (primary open-angle) | GCST90011766 | 0.04 |
| 8569 | PTPRN2/RTBDN ratio | GCST90315754 | 0.04 |
| 8570 | Diaphragmatic hernia | Hernia | UKBB00000172 | 0.04 |
| 8571 | X-12216 levels | GCST90200483 | 0.04 |
| 8572 | LMOD1 levels | GCST90469783 | 0.04 |
| 8573 | Rash and other nonspecific skin eruption (PheCode 687.1) | GCST90476167 | 0.04 |
| 8574 | Pregnenediol sulfate (C21H34O5S) levels | GCST90199861 | 0.04 |
| 8575 | LGALS9 levels | GCST90469765 | 0.04 |
| 8576 | Cholesteryl Esters to Total Lipids in Small HDL percentage | GCST90499406 | 0.04 |
| 8577 | DPEP1 levels | GCST90090302 | 0.04 |
| 8578 | Monocyte count | GCST004625 | 0.04 |
| 8579 | AXL/GAS6 ratio | GCST90313419 | 0.04 |
| 8580 | Pre-eclampsia | FING00001200 | 0.04 |
| 8581 | Reticulocyte count | Blood count | UKBB00000752 | 0.04 |
| 8582 | LYVE1 levels | GCST90469832 | 0.04 |
| 8583 | ESAM levels | GCST90469152 | 0.04 |
| 8584 | TFF1/TFF2 ratio | GCST90315914 | 0.04 |
| 8585 | Valine levels | GCST90132752 | 0.04 |
| 8586 | Shellfish liking | GCST90094838 | 0.04 |
| 8587 | SCARF2/TNFRSF21 ratio | GCST90315813 | 0.04 |
| 8588 | Left-hemisphere visual network to left-hemisphere control network white-matter structural connectivity | GCST90302653 | 0.04 |
| 8589 | aparc-a2009s rh area S-intrapariet+P-trans | GCST90003426 | 0.04 |
| 8590 | CD22 levels | GCST90468610 | 0.04 |
| 8591 | MATN2 levels | GCST90469864 | 0.04 |
| 8592 | CD40LG/EDAR ratio | GCST90313818 | 0.04 |
| 8593 | Ankylosing spondylitis, strict definition | FING00000090 | 0.04 |
| 8594 | Number of days/week walked 10+ minutes | Physical activity | UKBB00000535 | 0.04 |
| 8595 | Thyrotoxicosis with toxic multinodular goitre | FING00001362 | 0.04 |
| 8596 | Plasma 3-hydroxybutyroylglycine** levels in chronic kidney disease | GCST90264488 | 0.04 |
| 8597 | IgA nephropathy (IgA glomerulonephritis) | FING00000660 | 0.04 |
| 8598 | PRG3 levels | GCST90470323 | 0.04 |
| 8599 | Cholesterol in Medium HDL | GCST90498495 | 0.04 |
| 8600 | FYB1/MESD ratio | GCST90314911 | 0.04 |
| 8601 | Cholesterol in Medium HDL | GCST90498492 | 0.04 |
| 8602 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 0.04 |
| 8603 | CD59 levels | GCST90468639 | 0.04 |
| 8604 | EPO/TFRC ratio | GCST90314684 | 0.04 |
| 8605 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497732 | 0.04 |
| 8606 | ECHDC3 levels | GCST90469062 | 0.04 |
| 8607 | CTSC/PLA2G15 ratio | GCST90314311 | 0.04 |
| 8608 | KIFBP levels | GCST90469683 | 0.04 |
| 8609 | KEL levels | GCST90469673 | 0.04 |
| 8610 | SORD levels | GCST90470709 | 0.04 |
| 8611 | Total protein levels | GCST90018756 | 0.04 |
| 8612 | Creatinine levels | GCST90025946 | 0.04 |
| 8613 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 0.04 |
| 8614 | SERPINE2 levels | GCST90470597 | 0.04 |
| 8615 | SNAP29/TJAP1 ratio | GCST90315861 | 0.03 |
| 8616 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 0.03 |
| 8617 | HDL cholesterol | Blood biochemistry | UKBB00000306 | 0.03 |
| 8618 | CLEC14A levels | GCST90468766 | 0.03 |
| 8619 | GGH levels | GCST90469335 | 0.03 |
| 8620 | CFHR4 levels | GCST90019045 | 0.03 |
| 8621 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 0.03 |
| 8622 | HPGDS/ITGAV ratio | GCST90315080 | 0.03 |
| 8623 | Cholesteryl Esters in Large HDL | GCST90497751 | 0.03 |
| 8624 | DSG3/NECTIN4 ratio | GCST90314560 | 0.03 |
| 8625 | MMP1 levels | GCST90469919 | 0.03 |
| 8626 | CBLN4 levels | GCST90468554 | 0.03 |
| 8627 | WIF1 levels | GCST90471078 | 0.03 |
| 8628 | ABO levels | GCST90468191 | 0.03 |
| 8629 | COLEC12/LTBR ratio | GCST90314182 | 0.03 |
| 8630 | HHEX levels | GCST90469451 | 0.03 |
| 8631 | Recent feelings of depression | Depression | UKBB00000737 | 0.03 |
| 8632 | HHIP levels | GCST90617097 | 0.03 |
| 8633 | EFNB2 levels | GCST90469082 | 0.03 |
| 8634 | Blood clot / pulmonary embolism / deep vein thrombosis (DVT) | GCST90475209 | 0.03 |
| 8635 | wg lh intensity-contrast postcentral | GCST90003813 | 0.03 |
| 8636 | AKT3 levels | GCST90468278 | 0.03 |
| 8637 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497768 | 0.03 |
| 8638 | Left-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302738 | 0.03 |
| 8639 | Left-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302668 | 0.03 |
| 8640 | THOP1 levels | GCST90470856 | 0.03 |
| 8641 | Cognition and processing speed (confirmatory factor analysis Factor 34) | GCST90309368 | 0.03 |
| 8642 | rfMRI connectivity (ICA100 edge 383) | GCST90005236 | 0.03 |
| 8643 | Benign neoplasm: salivary glands, exclude unknown (D119) | FING00000199 | 0.03 |
| 8644 | Alcohol drinker status: current or former vs never (UKB data field 20117) | GCST90132923 | 0.03 |
| 8645 | Feeling hurt | GCST006951 | 0.03 |
| 8646 | Total lipids in large HDL | GCST90497818 | 0.03 |
| 8647 | aparc-a2009s lh volume G-cingul-Post-ventral | GCST90002934 | 0.03 |
| 8648 | Mean bone marrow fat fraction of left and right proximal femur | GCST90652394 | 0.03 |
| 8649 | Erysipelas | FING00000518 | 0.03 |
| 8650 | HLA-DMA levels | GCST90241448 | 0.03 |
| 8651 | Kidney volume | GCST90016670 | 0.03 |
| 8652 | Hearing aid user | Hearing | UKBB00000309 | 0.03 |
| 8653 | Creatinine | Blood biochemistry | UKBB00000156 | 0.03 |
| 8654 | SERPINA6 levels | GCST90470586 | 0.03 |
| 8655 | Plasma betaine levels in chronic kidney disease | GCST90264858 | 0.03 |
| 8656 | Otitis media (PheCode 381.1) | GCST90475903 | 0.03 |
| 8657 | CCR2 on CD14+ CD16- monocyte | GCST90002004 | 0.03 |
| 8658 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 0.03 |
| 8659 | Concentration of very large HDL particles | GCST90093011 | 0.03 |
| 8660 | Monocyte percentage | Blood count | UKBB00000480 | 0.03 |
| 8661 | Other circulatory problem | GCST90475217 | 0.03 |
| 8662 | BA-exvivo lh area BA45 | GCST90003215 | 0.03 |
| 8663 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 0.03 |
| 8664 | HSPB6/SNCG ratio | GCST90315090 | 0.03 |
| 8665 | Free cholesterol in LDL (UKB data field 23421) | GCST90269518 | 0.03 |
| 8666 | FIS1 levels | GCST90469240 | 0.03 |
| 8667 | Acquired foot deformities (PheCode 735) | GCST90476247 | 0.03 |
| 8668 | ZNRD2 levels | GCST90471103 | 0.03 |
| 8669 | Principal component-derived dietary pattern 18 | GCST90133023 | 0.03 |
| 8670 | PROK2 levels | GCST90617073 | 0.03 |
| 8671 | Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivity | GCST90302698 | 0.03 |
| 8672 | Abnormalities of forces of labour | FING00000003 | 0.03 |
| 8673 | IDP dMRI TBSS MO Body of corpus callosum | GCST90003955 | 0.03 |
| 8674 | Phospholipids in large LDL (UKB data field 23532) | GCST90269629 | 0.03 |
| 8675 | TNFSF14 levels | GCST90274842 | 0.03 |
| 8676 | BA-exvivo lh thickness BA4a | GCST90003517 | 0.03 |
| 8677 | Thyroid problems | GCST90475276 | 0.03 |
| 8678 | CD99/CD99L2 ratio | GCST90313923 | 0.03 |
| 8679 | PNLIP levels | GCST90470275 | 0.03 |
| 8680 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | GCST90475280 | 0.03 |
| 8681 | Mean corpuscular volume | GCST90002392 | 0.03 |
| 8682 | Alanine aminotransferase | Blood biochemistry | UKBB00000018 | 0.03 |
| 8683 | CST3 levels | UKBB00000163 | 0.03 |
| 8684 | Vanillactate levels | GCST90199978 | 0.03 |
| 8685 | Triglycerides to Total Lipids in Large HDL percentage | GCST90497896 | 0.03 |
| 8686 | Blood cell traits latent factor 1 (white cell) | GCST90559243 | 0.03 |
| 8687 | Benign neoplasm of major salivary glands | FING00000157 | 0.03 |
| 8688 | Hypothyroidism | GCST90018642 | 0.03 |
| 8689 | Gamma glutamyltransferase | Blood biochemistry | UKBB00000275 | 0.03 |
| 8690 | TGFBR2 levels | GCST90470847 | 0.03 |
| 8691 | aparc-a2009s lh volume S-intrapariet+P-trans | GCST90002980 | 0.03 |
| 8692 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320610 | 0.03 |
| 8693 | CDH2 levels | GCST90468673 | 0.03 |
| 8694 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.03 |
| 8695 | General happiness | Happiness and subjective well-being | UKBB00000280 | 0.03 |
| 8696 | CCL28 levels | GCST90468580 | 0.03 |
| 8697 | Benign paroxysmal vertigo | FING00000210 | 0.03 |
| 8698 | DBH levels | GCST90468948 | 0.03 |
| 8699 | 5alpha-androstan-3beta,17beta-diol disulfate levels | GCST90199835 | 0.03 |
| 8700 | FRZB levels | GCST90469269 | 0.03 |
| 8701 | ENTPD6 levels | GCST90469122 | 0.03 |
| 8702 | CD163/SIGLEC1 ratio | GCST90313739 | 0.03 |
| 8703 | Monocyte count (UKB data field 30130) | GCST90468090 | 0.03 |
| 8704 | AXIN1/CLIP2 ratio | GCST90313404 | 0.03 |
| 8705 | TIGIT levels | GCST90470865 | 0.03 |
| 8706 | SNAP23 levels | GCST90470690 | 0.03 |
| 8707 | CXCL13 levels | GCST90468926 | 0.03 |
| 8708 | PTPRB levels | GCST90470379 | 0.03 |
| 8709 | Deep venous thrombosis | GCST90468122 | 0.03 |
| 8710 | TYRP1 levels | GCST90470998 | 0.03 |
| 8711 | PRSS2 levels | GCST90470343 | 0.03 |
| 8712 | F-small fish liking (derived food-liking factor) | GCST90094840 | 0.03 |
| 8713 | POSTN levels | GCST90470288 | 0.03 |
| 8714 | PCSK7 levels | GCST90470176 | 0.03 |
| 8715 | Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels | GCST90200118 | 0.03 |
| 8716 | aseg global volume BrainSeg | GCST90002590 | 0.03 |
| 8717 | Noninfectious disorders of lymphatic channels (PheCode 450) | GCST90476002 | 0.03 |
| 8718 | CD38 levels | GCST90468628 | 0.03 |
| 8719 | Asthma with exacerbation (PheCode 495.2) | GCST90476025 | 0.03 |
| 8720 | Major depressive disorder | GCST009979 | 0.03 |
| 8721 | ANGPTL1 levels | GCST90468302 | 0.03 |
| 8722 | Crohn disease (strict definition, require KELA, min 2 HDR) | FING00000366 | 0.03 |
| 8723 | Urine proline levels in chronic kidney disease | GCST90265873 | 0.03 |
| 8724 | CRIP2 levels | GCST90468864 | 0.03 |
| 8725 | Neuroticism | GCST002920 | 0.03 |
| 8726 | DTI autoptx FA ifo l tract | GCST90385124 | 0.03 |
| 8727 | Oily fish consumption | GCST90132993 | 0.03 |
| 8728 | Alkenylphosphatidylcholine (P-36:3) levels | GCST90024954 | 0.03 |
| 8729 | Monocyte percentage of white cells | GCST004609 | 0.03 |
| 8730 | UBAC1 levels | GCST90470999 | 0.03 |
| 8731 | EGF/TNFSF14 ratio | GCST90314615 | 0.03 |
| 8732 | CA4 levels | GCST90468513 | 0.03 |
| 8733 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 0.03 |
| 8734 | CD48 levels | GCST90425676 | 0.03 |
| 8735 | ABHD14B/CRADD ratio | GCST90313141 | 0.03 |
| 8736 | Divergent concomitant strabismus | FING00000470 | 0.03 |
| 8737 | Left-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302737 | 0.03 |
| 8738 | EIF4B/MAP4K5 ratio | GCST90314623 | 0.03 |
| 8739 | Diabetes (weighted GWA) | GCST90267279 | 0.03 |
| 8740 | Intracerebral hemorrhage | GCST90018650 | 0.03 |
| 8741 | Feeling guilty | GCST006945 | 0.03 |
| 8742 | 5alpha-pregnan-3beta,20alpha-diol disulfate levels | GCST90199838 | 0.03 |
| 8743 | Urine taurocholenate sulfate* levels in chronic kidney disease | GCST90266041 | 0.03 |
| 8744 | LEG1 levels | GCST90469753 | 0.03 |
| 8745 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 0.03 |
| 8746 | DNAJC21 levels | GCST90469016 | 0.03 |
| 8747 | Basophil percentage of white cells | GCST90002380 | 0.03 |
| 8748 | CD80 on monocyte | GCST90002039 | 0.03 |
| 8749 | GP1BA/SDC4 ratio | GCST90314957 | 0.03 |
| 8750 | GFRA2 levels | GCST90469329 | 0.03 |
| 8751 | Mouth/teeth dental problems - Bleeding gums | Mouth | UKBB00000485 | 0.03 |
| 8752 | Free cholesterol in very large HDL | GCST90500380 | 0.03 |
| 8753 | aparc-DKTatlas lh volume superiorparietal | GCST90002889 | 0.03 |
| 8754 | Unspecified dementia | FING00001400 | 0.03 |
| 8755 | Peritonsillar abscess | FING00001160 | 0.03 |
| 8756 | Diabetes type 2 with peripheral circulatory (PheCode 250.25) | GCST90475678 | 0.03 |
| 8757 | Urine GlcNAc sulfate conjugate of C21H34O2 steroid** levels in chronic kidney disease | GCST90265175 | 0.03 |
| 8758 | OPLAH levels | GCST90470127 | 0.03 |
| 8759 | Basophill percentage | Blood count | UKBB00000087 | 0.03 |
| 8760 | REG1A/REG3A ratio | GCST90315761 | 0.03 |
| 8761 | Estimated glomerular filtration rate, serum creatinine | Other measurement | UKBB00000212 | 0.03 |
| 8762 | GALNT10 levels | GCST90469295 | 0.03 |
| 8763 | Glaucoma (multi-trait analysis) | GCST009722 | 0.03 |
| 8764 | HBEGF/WWP2 ratio | GCST90315038 | 0.03 |
| 8765 | Acute laryngitis and tracheitis | FING00000023 | 0.03 |
| 8766 | Serum 25-Hydroxyvitamin D levels | GCST90000614 | 0.03 |
| 8767 | AGR2 levels | GCST90468253 | 0.03 |
| 8768 | F11R/GP1BA ratio | GCST90314722 | 0.03 |
| 8769 | Diseases of the digestive system | FING00000429 | 0.03 |
| 8770 | Total concentration of branched-chain amino acids (leucine + isoleucine + valine) (UKB data field 23464) | GCST90269561 | 0.03 |
| 8771 | DTI TBSS MO Middle cerebellar peduncle | GCST90384620 | 0.03 |
| 8772 | Polyunsaturated fatty acid levels | GCST90502623 | 0.03 |
| 8773 | CDH5/LGALS4 ratio | GCST90313956 | 0.03 |
| 8774 | Visual disturbances | FING00001437 | 0.03 |
| 8775 | Anterior diffusion tensor imaging along the perivascular space index | GCST90455543 | 0.03 |
| 8776 | Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels | GCST90060311 | 0.03 |
| 8777 | HBEGF/PLXNA4 ratio | GCST90315036 | 0.03 |
| 8778 | SHBG levels | UKBB00000767 | 0.03 |
| 8779 | mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed) | GCST90475460 | 0.03 |
| 8780 | Clinical LDL cholesterol levels (UKB data field 23404) | GCST90269501 | 0.03 |
| 8781 | Cis-4-decenoylcarnitine (C10:1) metabolite level | GCST90615729 | 0.03 |
| 8782 | C1QTNF5 levels | GCST90468489 | 0.03 |
| 8783 | Total Ceramide levels | GCST90025817 | 0.03 |
| 8784 | Total Dihexosylceramide levels | GCST90025821 | 0.03 |
| 8785 | CNPY4 levels | GCST90468800 | 0.03 |
| 8786 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T434 | ECGU000434 | 0.03 |
| 8787 | Indolebutyrate levels | GCST90199759 | 0.03 |
| 8788 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90024504 | 0.03 |
| 8789 | SYTL4 levels | GCST90470795 | 0.03 |
| 8790 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668524 | 0.03 |
| 8791 | Obesity related asthma | FING00000897 | 0.03 |
| 8792 | FUT8/SORT1 ratio | GCST90314892 | 0.03 |
| 8793 | CLEC1B levels | GCST90468768 | 0.03 |
| 8794 | Right-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302831 | 0.03 |
| 8795 | Other reaction to severe stress, and adjustment disorders | FING00001092 | 0.03 |
| 8796 | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302676 | 0.03 |
| 8797 | Colon polyp | GCST90018607 | 0.03 |
| 8798 | Phospholipids in medium HDL | GCST90498635 | 0.03 |
| 8799 | GOT1 levels | GCST90469379 | 0.03 |
| 8800 | Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers) | FING00000143 | 0.03 |
| 8801 | DTI TBSS L2 Cingulum hippocampus L | GCST90384513 | 0.03 |
| 8802 | KLK8/NECTIN4 ratio | GCST90315258 | 0.03 |
| 8803 | CST5 levels | GCST90468895 | 0.03 |
| 8804 | IFNAR1 levels | GCST90469512 | 0.03 |
| 8805 | N-acetylglycine levels | GCST90243561 | 0.03 |
| 8806 | Triacylglycerol_51:4_[M+NH4]1+ levels | GCST90060491 | 0.03 |
| 8807 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 73) | GCST90320636 | 0.03 |
| 8808 | CSF1/SEMA3F ratio | GCST90314288 | 0.03 |
| 8809 | SUSD1/THPO ratio | GCST90315899 | 0.03 |
| 8810 | PIK3IP1 levels | GCST90470234 | 0.03 |
| 8811 | aparc-a2009s lh area G-pariet-inf-Supramar | GCST90003322 | 0.03 |
| 8812 | IDP dMRI TBSS L3 Posterior limb of internal capsule L | GCST90004190 | 0.03 |
| 8813 | CD19 on IgD- CD38- B cell | GCST90001733 | 0.03 |
| 8814 | Visceral adipose tissue normalized | GCST90267358 | 0.03 |
| 8815 | 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels | GCST90200065 | 0.03 |
| 8816 | Plasma N-acetyltaurine levels in chronic kidney disease | GCST90265600 | 0.03 |
| 8817 | Childhood maltreatment | GCST90551844 | 0.03 |
| 8818 | HSPG2/IGFBP6 ratio | GCST90315091 | 0.03 |
| 8819 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 0.03 |
| 8820 | CCN2/TPP1 ratio | GCST90313718 | 0.03 |
| 8821 | Spells in hospital | Summary Administration | UKBB00000789 | 0.03 |
| 8822 | SETMAR levels | GCST90470605 | 0.02 |
| 8823 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 0.02 |
| 8824 | CDA levels | GCST90468660 | 0.02 |
| 8825 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 0.02 |
| 8826 | DCBLD2 levels | GCST90468952 | 0.02 |
| 8827 | Volume of left cortical nucleus | GCST90474886 | 0.02 |
| 8828 | Average diameter for HDL particles | GCST90497454 | 0.02 |
| 8829 | Obstructive sleep apnea (PheCode 327.32) | GCST90475825 | 0.02 |
| 8830 | Gallbladder polyp | GCST90018626 | 0.02 |
| 8831 | Free cholesterol in medium HDL | GCST90498562 | 0.02 |
| 8832 | Valine levels | GCST90092995 | 0.02 |
| 8833 | Asthma-related pneumonia | FING00000119 | 0.02 |
| 8834 | aparc-a2009s rh area S-oc-middle+Lunatus | GCST90003427 | 0.02 |
| 8835 | HLA-DQA2 levels | GCST90427049 | 0.02 |
| 8836 | Alcohol drinker status: current vs never (UKB data field 20117) | GCST90132924 | 0.02 |
| 8837 | Right-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302804 | 0.02 |
| 8838 | IL16 levels | GCST90469557 | 0.02 |
| 8839 | EPHB4 levels | GCST90469132 | 0.02 |
| 8840 | Lateral epicondylitis | FING00000715 | 0.02 |
| 8841 | TAB2 levels | GCST90470796 | 0.02 |
| 8842 | ESAM/THPO ratio | GCST90314719 | 0.02 |
| 8843 | NFX1 levels | GCST90470041 | 0.02 |
| 8844 | GDF2 levels | GCST90469322 | 0.02 |
| 8845 | Glaucoma suspect | FING00000579 | 0.02 |
| 8846 | NCAM1 levels | GCST90470003 | 0.02 |
| 8847 | Type1 diabetes, definitions combined, early onset | FING00001384 | 0.02 |
| 8848 | Left-hemisphere visual network to left-hemisphere limbic network white-matter structural connectivity | GCST90302652 | 0.02 |
| 8849 | CALCB levels | GCST90468529 | 0.02 |
| 8850 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 0.02 |
| 8851 | Prescriptions - anti-malarial | UKBB00000663 | 0.02 |
| 8852 | Glomerular disorders in diseases classified elsewhere | FING00000582 | 0.02 |
| 8853 | SPARC/TJAP1 ratio | GCST90315873 | 0.02 |
| 8854 | aparc-DKTatlas lh volume precuneus | GCST90002885 | 0.02 |
| 8855 | F-salad vegetables liking (derived food-liking factor) | GCST90094824 | 0.02 |
| 8856 | IL27 levels | GCST90469060 | 0.02 |
| 8857 | Right-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302848 | 0.02 |
| 8858 | Diacylglycerol_33:1_[M+H-H2O]1+ levels | GCST90060173 | 0.02 |
| 8859 | CFP levels | GCST90468731 | 0.02 |
| 8860 | Glycoprotein acetyls levels | GCST90497328 | 0.02 |
| 8861 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 0.02 |
| 8862 | Irritable mood | GCST006941 | 0.02 |
| 8863 | SBSN levels | GCST90470531 | 0.02 |
| 8864 | Hair colour (natural, before greying): Black (UKB data field 1747_5) | GCST90041840 | 0.02 |
| 8865 | Benign neoplasm: Colon, unspecified | FING00000172 | 0.02 |
| 8866 | Nonalcoholic fatty liver disease | GCST90275041 | 0.02 |
| 8867 | TIE1 levels | GCST90470863 | 0.02 |
| 8868 | ICAM2/IL7R ratio | GCST90315117 | 0.02 |
| 8869 | Total Lipids in HDL | GCST90497393 | 0.02 |
| 8870 | Left-hemisphere control network to caudate white-matter structural connectivity | GCST90302753 | 0.02 |
| 8871 | Hemoglobin A1c levels | GCST90278632 | 0.02 |
| 8872 | Creatinine levels | GCST90092815 | 0.02 |
| 8873 | BCAN levels | GCST90468426 | 0.02 |
| 8874 | Free cholesterol in medium LDL (UKB data field 23542) | GCST90269639 | 0.02 |
| 8875 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 0.02 |
| 8876 | Other specified diseases of sebaceous glands (PheCode 706.8) | GCST90476215 | 0.02 |
| 8877 | Past tobacco smoking | Smoking | UKBB00000635 | 0.02 |
| 8878 | DPP10 levels | GCST90469032 | 0.02 |
| 8879 | Tooth agenesis EXCLUDE clefts and syndromes | FING00001368 | 0.02 |
| 8880 | Lower back pain or/and sciatica | FING00000731 | 0.02 |
| 8881 | ANG/F9 ratio | GCST90313259 | 0.02 |
| 8882 | Uric acid levels | GCST90278646 | 0.02 |
| 8883 | Flat foot [pes planus] (acquired) | FING00000545 | 0.02 |
| 8884 | Malignant melanoma | GCST90468141 | 0.02 |
| 8885 | BCR/NFATC1 ratio | GCST90313496 | 0.02 |
| 8886 | AmygNuclei rh volume Lateral-nucleus | GCST90002658 | 0.02 |
| 8887 | Interpolated Age of participant when operation took place | Operations | UKBB00000370 | 0.02 |
| 8888 | Degree of unsaturation | GCST90502734 | 0.02 |
| 8889 | Other enthesopathies | FING00001045 | 0.02 |
| 8890 | Belief that own life is meaningful | Happiness and subjective well-being | UKBB00000090 | 0.02 |
| 8891 | Heart rate variability traits (RMSSD) | GCST004733 | 0.02 |
| 8892 | Calcium levels | GCST90018731 | 0.02 |
| 8893 | Liver proton density fat fraction | GCST90267352 | 0.02 |
| 8894 | Principal component-derived dietary pattern 45 | GCST90133050 | 0.02 |
| 8895 | Left-hemisphere dorsal attention network to right-hemisphere control network white-matter structural connectivity | GCST90302699 | 0.02 |
| 8896 | APP/VEGFC ratio | GCST90313333 | 0.02 |
| 8897 | Pregnenediol disulfate (C21H34O8S2) levels | GCST90199840 | 0.02 |
| 8898 | Foveal thickness | GCST90624113 | 0.02 |
| 8899 | SPARC levels | GCST90470718 | 0.02 |
| 8900 | Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000641 | 0.02 |
| 8901 | aseg global volume WM-hypointensities | GCST90002604 | 0.02 |
| 8902 | BACH1 levels | GCST90468415 | 0.02 |
| 8903 | mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed) | GCST90475456 | 0.02 |
| 8904 | ALPP levels | GCST90468286 | 0.02 |
| 8905 | ALCAM/SPINT1 ratio | GCST90313242 | 0.02 |
| 8906 | CD22/CD79B ratio | GCST90313755 | 0.02 |
| 8907 | IDP dMRI TBSS MD Posterior limb of internal capsule R | GCST90004045 | 0.02 |
| 8908 | DTI TBSS L2 Superior cerebellar peduncle R | GCST90384488 | 0.02 |
| 8909 | Cholesterol to Total Lipids in Medium HDL percentage | GCST90498516 | 0.02 |
| 8910 | PIK3IP1/RGMB ratio | GCST90315652 | 0.02 |
| 8911 | Left-hemisphere dorsal attention network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302696 | 0.02 |
| 8912 | Bipolar and major depression status - No Bipolar or Depression | Mental health | UKBB00000094 | 0.02 |
| 8913 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 0.02 |
| 8914 | Phospholipids to total lipids in small HDL percentage (UKB data field 23644) | GCST90269741 | 0.02 |
| 8915 | DSC2/SPINT1 ratio | GCST90314557 | 0.02 |
| 8916 | CA4/TNFSF12 ratio | GCST90313589 | 0.02 |
| 8917 | CD5/TNFRSF9 ratio | GCST90313862 | 0.02 |
| 8918 | VIT levels | GCST90471041 | 0.02 |
| 8919 | Granulocyte percentage of myeloid white cells | GCST004608 | 0.02 |
| 8920 | Cholesteryl Esters to Total Lipids in Medium HDL percentage | GCST90498556 | 0.02 |
| 8921 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433 | ECGU000433 | 0.02 |
| 8922 | Frequency of tenseness / restlessness in last 2 weeks | Mental health | UKBB00000267 | 0.02 |
| 8923 | Cancer of prostate | neoplasms | UKBB00000118 | 0.02 |
| 8924 | Hepatomegaly (PheCode 573.3) | GCST90476092 | 0.02 |
| 8925 | Treatment/medication code - ramipril | Medications | UKBB00000856 | 0.02 |
| 8926 | ERP29 levels | GCST90088843 | 0.02 |
| 8927 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 44) | GCST90320863 | 0.02 |
| 8928 | Monocyte percentage (UKB data field 30190) | GCST90468091 | 0.02 |
| 8929 | CDH3/TNFRSF21 ratio | GCST90313953 | 0.02 |
| 8930 | CCL5 levels | GCST90468584 | 0.02 |
| 8931 | PLXNA4/USP8 ratio | GCST90315690 | 0.02 |
| 8932 | AXIN1 levels | GCST90468405 | 0.02 |
| 8933 | CXCL10/WARS ratio | GCST90314332 | 0.02 |
| 8934 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.02 |
| 8935 | Total Ceramide levels | GCST90024578 | 0.02 |
| 8936 | Fibroblastic disorders | FING00000542 | 0.02 |
| 8937 | MMP1/SERPINB6 ratio | GCST90315462 | 0.02 |
| 8938 | Basophil count | GCST90002379 | 0.02 |
| 8939 | X-13435 levels | GCST90243811 | 0.02 |
| 8940 | CA5A/KRT18 ratio | GCST90313592 | 0.02 |
| 8941 | Diacylglycerol_32:2_[M+H-H2O]1+ levels | GCST90060168 | 0.02 |
| 8942 | CASP10/ING1 ratio | GCST90313625 | 0.02 |
| 8943 | Operation code - pilonidal sinus surgery (anal) | Operations | UKBB00000563 | 0.02 |
| 8944 | REG4 levels | GCST90470451 | 0.02 |
| 8945 | Seen doctor (GP) for nerves, anxiety, tension or depression | Mental health | UKBB00000765 | 0.02 |
| 8946 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 0.02 |
| 8947 | CC2D1A/CRADD ratio | GCST90313663 | 0.02 |
| 8948 | 5-hydroxyindole sulfate levels | GCST90200050 | 0.02 |
| 8949 | Alcoholic liver disease | FING00000057 | 0.02 |
| 8950 | SUOX levels | GCST90470785 | 0.02 |
| 8951 | ARNT levels | GCST90468367 | 0.02 |
| 8952 | ITGB1/MCAM ratio | GCST90315226 | 0.02 |
| 8953 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 0.02 |
| 8954 | Cholesterol in large LDL (UKB data field 23533) | GCST90269630 | 0.02 |
| 8955 | HAO1 levels | GCST90469429 | 0.02 |
| 8956 | F-capsicum liking (derived food-liking factor) | GCST90094726 | 0.02 |
| 8957 | HGF/PLAUR ratio | GCST90315059 | 0.02 |
| 8958 | F8 levels | GCST90240725 | 0.02 |
| 8959 | HSIL lesion of the cervix uteri | FING00000624 | 0.02 |
| 8960 | CD5 levels | GCST90274773 | 0.02 |
| 8961 | Cardiorespiratory fitness slope | GCST90093320 | 0.02 |
| 8962 | AGXT levels | GCST90468258 | 0.02 |
| 8963 | HCLS1 levels | GCST90469437 | 0.02 |
| 8964 | Sphingomyelin (d18:0/16:0) levels | GCST90025741 | 0.02 |
| 8965 | LDL cholesterol levels (UKB data field 23405) | GCST90269502 | 0.02 |
| 8966 | Alanine levels | GCST90497085 | 0.02 |
| 8967 | CRNN levels | GCST90277890 | 0.02 |
| 8968 | CLIP2/NT5C3A ratio | GCST90314129 | 0.02 |
| 8969 | Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels | GCST90060307 | 0.02 |
| 8970 | Phospholipids in LDL (UKB data field 23413) | GCST90269510 | 0.02 |
| 8971 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 0.02 |
| 8972 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 0.02 |
| 8973 | Neuroticism | GCST003770 | 0.02 |
| 8974 | COL6A3/OGN ratio | GCST90314177 | 0.02 |
| 8975 | Monocyte count | GCST90025950 | 0.02 |
| 8976 | CCL3 levels | GCST90012055 | 0.02 |
| 8977 | ENTPD2 levels | GCST90469120 | 0.02 |
| 8978 | magnesium (Mg, maximum, inv-norm transformed) | GCST90475477 | 0.02 |
| 8979 | Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers) | FING00001330 | 0.02 |
| 8980 | Docosahexaenoic acid to total fatty acids percentage | GCST90502280 | 0.02 |
| 8981 | IKBKG levels | GCST90469542 | 0.02 |
| 8982 | CD302/IL12A_IL12B ratio | GCST90313806 | 0.02 |
| 8983 | SSC4D levels | GCST90470747 | 0.02 |
| 8984 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 0.02 |
| 8985 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 31) | GCST90320850 | 0.02 |
| 8986 | Use of disulfiram, acamprosate or naltrexone | FING00001410 | 0.02 |
| 8987 | MED18/ZBTB16 ratio | GCST90315416 | 0.02 |
| 8988 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 0.02 |
| 8989 | KYNU/SCLY ratio | GCST90315265 | 0.02 |
| 8990 | aparc-Desikan lh volume superiorparietal | GCST90002796 | 0.02 |
| 8991 | CD300E/CXCL10 ratio | GCST90313796 | 0.02 |
| 8992 | SMAD1/ZBTB16 ratio | GCST90315853 | 0.02 |
| 8993 | GSTA1/KRT18 ratio | GCST90314993 | 0.02 |
| 8994 | LEFTY2 levels | GCST90469752 | 0.02 |
| 8995 | Basal cell carcinoma, excluding all cancers (controls excluding all cancers) | FING00000142 | 0.02 |
| 8996 | Interpolated Year when operation took place | Operations | UKBB00000372 | 0.02 |
| 8997 | Fasciitis (PheCode 728.7) | GCST90476244 | 0.02 |
| 8998 | CX3CL1 levels | GCST90468921 | 0.02 |
| 8999 | Viral hepatitis (PheCode 70) | GCST90475552 | 0.02 |
| 9000 | FOLH1 levels | GCST90469258 | 0.02 |